Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00816335 · ClinicalTrials.gov registry record · Early Phase 1
Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors
A Early Phase 1 study of Unspecified Adult Solid Tumor, Protocol Specific, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 65
- Enrollment target
- 1
- Study location
NCT00816335 is a Early Phase 1 study of Unspecified Adult Solid Tumor, Protocol Specific that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 65 participants, below the 500-participant average among 83 other Unspecified Adult Solid Tumor, Protocol Specific trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00816335, a Early Phase 1 study of Unspecified Adult Solid Tumor, Protocol Specific, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to evaluate a combined and integrated technological approach of 18F-FDG-directed perioperative PET/CT imaging and intraoperative handheld gamma probe detection of known and occult disease in patients undergoing surgery for solid malignancies.
Conditions Studied
Interventions
- PROCEDURE Surgical Procedure
- PROCEDURE PET/CT scan
- DRUG 18F-FDG Injection
- PROCEDURE Preoperative 18F-FDG PET/CT Scan
- DRUG 18F-FDG for patients with Bladder Cancer
Study Locations (1)
Ohio
- Ohio State University Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-08 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00816335
The ClinicalTrials.gov registry entry for NCT00816335 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 500-participant average among 83 other Unspecified Adult Solid Tumor, Protocol Specific trials with a reported enrollment target (87% lower). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Unspecified Adult Solid Tumor, Protocol Specific appearing as the primary indexed condition, and to 5 interventions - of which Surgical Procedure is the first listed.
NCT00816335 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00816335 about?
NCT00816335 is a clinical study titled "Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors". The purpose of this pilot study is to evaluate a combined and integrated technological approach of 18F-FDG-directed perioperative PET/CT imaging and intraoperative handheld gamma probe detection of known and occult disease in patients undergoing surgery for solid malignancies.
What is the current status of trial NCT00816335?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 65 participants. The study started on 2008-10. Estimated completion is 2011-08.
What conditions does trial NCT00816335 study?
This clinical trial studies the following conditions: Unspecified Adult Solid Tumor, Protocol Specific.
What interventions are being tested in trial NCT00816335?
The interventions under investigation include: Surgical Procedure (PROCEDURE), PET/CT scan (PROCEDURE), 18F-FDG Injection (DRUG), Preoperative 18F-FDG PET/CT Scan (PROCEDURE), 18F-FDG for patients with Bladder Cancer (DRUG).
Who is sponsoring clinical trial NCT00816335?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00816335 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Unspecified Adult Solid Tumor, Protocol Specific
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
RECRUITING
-
Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors
RECRUITING
-
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
RECRUITING
-
Registry of Older Patients With Cancer
RECRUITING
-
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
RECRUITING
-
RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.